ENTRADA THERAPEUTICS INC (TRDA) Institutional Shareholders
ENTRADA THERAPEUTICS INC (TRDA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $214.49M in TRDA holdings during the latest filing period.
Baker Bros. Advisors Lp is currently the largest disclosed institutional shareholder of TRDA tracked by InsiderSet, reporting ownership valued at approximately $37.34M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $35.00M, representing an estimated loss of -6.25% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 67% of the total disclosed TRDA value among the investors covered in this analysis. Major shareholders include Baker Bros. Advisors Lp, 5Am Venture Management, Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in ENTRADA THERAPEUTICS INC (TRDA).
This page ranks the largest institutional TRDA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
128
Total Reported Value
$214.49M
Largest Holder
Baker Bros. Advisors Lp
Largest Position
$37.34M
Insider Transactions (90d)
33
Latest Filing Quarter
Q2 2026
New Institutional Positions
137
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Baker Bros. Advisors Lp | 0.19% | 5,072,730 | $37,335,293 | $35,001,837 | -$2,333,456 | -6.25% | |
| 5Am Venture Management, Llc | 10.37% | 4,056,379 | $29,854,949 | $27,989,015 | -$1,865,934 | -6.25% | |
| Blackrock, Inc. | 0.00% | 2,583,333 | $19,013,332 | $17,824,998 | -$1,188,334 | -6.25% | |
| Merck & Co., Inc. | 2.43% | 1,739,768 | $12,804,692 | $12,004,399 | -$800,293 | -6.25% | |
| Vanguard Capital Management Llc | 0.00% | 1,269,634 | $9,344,506 | $8,760,475 | -$584,031 | -6.25% | |
| Mpm Bioimpact Llc | 0.56% | 1,253,053 | $9,222,470 | $8,646,066 | -$576,404 | -6.25% | |
| Tcg Crossover Management, Llc | 0.19% | 1,060,230 | $7,803,293 | $7,315,587 | -$487,706 | -6.25% | |
| Wellington Management Group Llp | 0.00% | 954,419 | $7,024,524 | $6,585,491 | -$439,033 | -6.25% | |
| Millennium Management Llc | 0.00% | 763,959 | $5,622,738 | $5,271,317 | -$351,421 | -6.25% | |
| Stepstone Group Lp | 0.26% | 761,277 | $5,602,999 | $5,252,811 | -$350,188 | -6.25% | |
| Geode Capital Management, Llc | 0.00% | 717,430 | $5,281,368 | $4,950,267 | -$331,101 | -6.27% | |
| Aqr Capital Management Llc | 0.00% | 699,537 | $5,148,591 | $4,826,805 | -$321,786 | -6.25% | |
| State Street Corp | 0.00% | 596,677 | $4,391,543 | $4,117,071 | -$274,472 | -6.25% | |
| Price T Rowe Associates Inc | 0.00% | 542,316 | $3,992,000 | $3,741,980 | -$250,020 | -6.26% | |
| Jpmorgan Chase & Co | 0.00% | 496,457 | $3,827,683 | $3,425,553 | -$402,130 | -10.51% | |
| Acadian Asset Management Llc | 0.00% | 400,862 | $2,945,000 | $2,765,948 | -$179,052 | -6.08% | |
| Citadel Advisors Llc | 0.00% | 394,323 | $2,902,217 | $2,720,829 | -$181,388 | -6.25% | |
| Dimensional Fund Advisors Lp | 0.00% | 376,136 | $2,769,577 | $2,595,338 | -$174,239 | -6.29% | |
| Northern Trust Corp | 0.00% | 309,942 | $2,281,173 | $2,138,600 | -$142,573 | -6.25% | |
| Jacobs Levy Equity Management, Inc | 0.01% | 303,459 | $2,233,458 | $2,093,867 | -$139,591 | -6.25% | |
| Nantahala Capital Management, Llc | 0.13% | 300,575 | $2,212,232 | $2,073,968 | -$138,265 | -6.25% | |
| Vanguard Portfolio Management Llc | 0.00% | 254,130 | $1,870,397 | $1,753,497 | -$116,900 | -6.25% | |
| Charles Schwab Investment Management Inc | 0.00% | 197,136 | $1,450,921 | $1,360,238 | -$90,683 | -6.25% | |
| Longaeva Partners L.P. | 0.04% | 195,237 | $1,436,944 | $1,347,135 | -$89,809 | -6.25% | |
| Morgan Stanley | 0.00% | 191,650 | $1,410,544 | $1,322,385 | -$88,159 | -6.25% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 191,000 | $1,405,760 | $1,317,900 | -$87,860 | -6.25% |
| Quantinno Capital Management Lp | 0.00% | 188,839 | $1,389,855 | $1,302,989 | -$86,866 | -6.25% | |
| Lynx1 Capital Management Lp | 0.15% | 178,606 | $1,314,540 | $1,232,381 | -$82,159 | -6.25% | |
| Goldman Sachs Group Inc | 0.00% | 177,343 | $1,305,247 | $1,223,667 | -$81,580 | -6.25% | |
| Vanguard Fiduciary Trust Co | 0.00% | 167,646 | $1,233,875 | $1,156,757 | -$77,118 | -6.25% | |
| Woodline Partners Lp | 0.00% | 145,600 | $1,071,616 | $1,004,640 | -$66,976 | -6.25% | |
| Trexquant Investment Lp | 0.01% | 140,143 | $1,031,452 | $966,987 | -$64,465 | -6.25% | |
| Moore Capital Management, Lp | 0.02% | 105,000 | $772,800 | $724,500 | -$48,300 | -6.25% | |
| Xtx Topco Ltd | 0.01% | 95,337 | $701,680 | $657,825 | -$43,855 | -6.25% | |
| Bnp Paribas Financial Markets | 0.00% | 95,044 | $699,524 | $655,804 | -$43,720 | -6.25% | |
| Allspring Global Investments Holdings, Llc | 0.00% | 93,538 | $688,440 | $645,412 | -$43,028 | -6.25% | |
| Gsa Capital Partners Llp | 0.04% | 88,005 | $648,000 | $607,235 | -$40,766 | -6.29% | |
| Royce & Associates Lp | 0.00% | 82,902 | $610,159 | $572,024 | -$38,135 | -6.25% | |
| American Century Companies Inc | 0.00% | 79,701 | $586,599 | $549,937 | -$36,662 | -6.25% | |
| Bank Of New York Mellon Corp | 0.00% | 79,070 | $581,955 | $545,583 | -$36,372 | -6.25% | |
| Manufacturers Life Insurance Company, The | 0.00% | 72,520 | $533,747 | $500,388 | -$33,359 | -6.25% | |
| Ameriprise Financial Inc | 0.00% | 70,395 | $518,107 | $485,726 | -$32,382 | -6.25% | |
| Qube Research & Technologies Ltd | 0.00% | 60,872 | $448,018 | $420,017 | -$28,001 | -6.25% | |
| Cantor Fitzgerald, L. P. | 0.01% | 60,000 | $441,600 | $414,000 | -$27,600 | -6.25% | |
| Bank Of America Corp | 0.00% | 57,927 | $426,343 | $399,696 | -$26,647 | -6.25% | |
| Nuveen, Llc | 0.00% | 56,777 | $417,879 | $391,761 | -$26,118 | -6.25% | |
| Alliancebernstein L.P. | 0.00% | 31,640 | $399,297 | $218,316 | -$180,981 | -45.32% | |
| Susquehanna Portfolio Strategies, Llc | 0.01% | 54,113 | $398,272 | $373,380 | -$24,892 | -6.25% | |
| Td Asset Management Inc | 0.00% | 53,588 | $394,408 | $369,757 | -$24,651 | -6.25% | |
| Exoduspoint Capital Management, Lp | 0.00% | 52,767 | $388,365 | $364,092 | -$24,273 | -6.25% |
Frequently asked questions about TRDA
Who owns the most TRDA stock?
The largest holders of TRDA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ENTRADA THERAPEUTICS INC (TRDA).
Is TRDA widely held by superinvestors?
Many widely followed stocks like TRDA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TRDA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.